AGENT™ H7493960815350Recalls & reported problems
Boston Scientific Corporation · Paclitaxel-Coated Balloon Catheter · Class 3
All models of AGENT (23)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00191506014766), received between Jul 3, 2025 and Mar 30, 2026 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break3
- Adverse Event Without Identified Device or Use Problem1
- Deformation Due to Compressive Stress1
- Device-Device Incompatibility1
- Difficult to Advance1
- Entrapment of Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 30, 2026Break
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED. A 3.50 MM X 15.00 MM AGENT DRUG-COATED BALLOON (DCB) WAS SELECTED FOR TREATMENT OF IN-STENT RESTENOSIS (ISR). DURING REMOVAL, THE SHAFT OF THE BALLOON CATHETER FRACTURED. THE DEVICE WAS REMOVED, AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS, AND THE PATIENT FULLY RECOVERED AFTER THE PROCEDURE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24730372 ↗MalfunctionDec 9, 2025Break; Entrapment of Device; Deformation Due to Compressive Stress; Device-Device Incompatibility; Break; Entrapment of Device; Deformation Due to Compressive Stress; Device-Device Incompatibility
IT WAS REPORTED THAT DEVICE ENTRAPPED AND SHAFT BREAK OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERY DISEASE. A 3.50 X 15 MM AGENT DRUG-COATED BALLOON (DCB) WAS SELECTED FOR PERCUTANEOUS CORONARY INTERVENTION (PCI). DURING INSERTION, THE BALLOON BECAME STUCK WITHIN THE GUIDE EXTENSION, RESULTING IN SHAFT BENT AND BRAKE. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER DEVICE. THERE WAS NO PATIENT COMPLICATIONS REPORTED, AND THE PATIENT WAS FULLY RECOVERED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23756759 ↗MalfunctionJul 3, 2025Break; Difficult to Advance; Adverse Event Without Identified Device or Use Problem; Break; Difficult to Advance; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED. AN AGENT US MR 3.50 X 15MM WAS SELECTED FOR TREATMENT OF THE TARGET LESION, WHICH WAS LOCATED IN THE PROXIMAL CIRCUMFLEX. FOLLOWING IVUS, THE PHYSICIAN BEGAN ATTEMPTING TO ADVANCE THE AGENT BALLOON. IT WAS NOTED THAT THERE WAS DIFFICULTY ADVANCING THE BALLOON. WHEN ATTEMPTING TO PROPERLY POSITION THE BALLOON, THE PROXIMAL END OF THE DEVICE BROKE, JUST BEFORE THE BALLOON. THE PHYSICIAN WAS ABLE TO COMPLETELY REMOVE THE AGENT FROM THE PATIENT, AND ANOTHER SIMILAR DEVICE WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22395731 ↗
Other Drug-eluting percutaneous transluminal coronary angioplasty catheter devices
- AGENT™ H7493960830250Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter10 reports
- AGENT™ H7493960830300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter8 reports
- AGENT™ H7493960820300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter8 reports
- AGENT™ H7493960820250Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter6 reports
- AGENT™ H7493960830400Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter6 reports
- AGENT™ H7493960830350Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
- AGENT™ H7493960820400Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
- AGENT™ H7493960815300Boston Scientific Corporation · Drug-eluting percutaneous transluminal coronary angioplasty catheter5 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page